Arkolith/Insider Trading/BCAX/Form 4

Hyep Ivan

Chief Financial OfficerBicara Therapeutics Inc. (BCAX) · full profile →Form 4 · filed Mar 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$301K
Net Open-Market Flow
-$301K
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)3K$18.25$54K145K
Mar 4, 2026Option exercise(M)3K$3.79$11K148K
Mar 3, 2026Option exercise(M)7K$3.79$28K153K
Mar 3, 2026Sell(S)14K$18.22$247K145K
Mar 3, 2026Option exercise(M)6K$3.79$24K159K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)3K—$080K
Mar 3, 2026Option exercise(M)6K—$083K
Mar 3, 2026Option exercise(M)7K—$058K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015421) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML